PPIPT01874
Target Protein Information
| Protein_Name | Melanoma-associated antigen 6 |
|---|---|
| Protein_Sequence | MPLEQRSQHCKPEEGLEARGEALGLVGAQAPATEEQEAASSSSTLVEVTLGEVPAAESPDPPQSPQGASSLPTTMNYPLWSQSYEDSSNQEEEGPSTFPDLESEFQAALSRKVAKLVHFLLLKYRAREPVTKAEMLGSVVGNWQYFFPVIFSKASDSLQLVFGIELMEVDPIGHVYIFATCLGLSYDGLLGDNQIMPKTGFLIIILAIIAKEGDCAPEEKIWEELSVLEVFEGREDSIFGDPKKLLTQYFVQENYLEYRQVPGSDPACYEFLWGPRALIETSYVKVLHHMVKISGGPRISYPLLHEWALREGEE |
| Organism_Source | Homo sapiens |
| Functional_Classification | Cancer/testis antigen |
| Cellular_Localization | Cytoplasm |
| Gene_Names | MAGEA6 |
| UniProt_ID | P43360 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | MAGEA6_A0301 |
|---|---|
| Peptide_Sequence | YLFPVIFSK |
| Peptide_Length | 9 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Free |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 1113.36 |
|---|---|
| Aliphatic_Index | 118.88889 |
| Aromaticity | 0.33333 |
| Average_Rotatable_Bonds | 3.55556 |
| Charge_at_pH_7 | 0.99684 |
| Isoelectric_point | 9.29830 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 13 |
| Number_of_Hydrogen_Bond_Donors | 12 |
| Topological_Polar_Surface_Area | 353.81000 |
| X_logP_energy | 1.08610 |
Interaction Information
| Affinity | IC50=50.31 nM |
|---|---|
| Affinity_Assay | ProImmune REVEAL assay |
| PDB_ID | None |
| Type | Affinity ligand |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | IMMUNOGENIC HETEROCLITIC PEPTIDES FROM CANCER - ASSOCIATED PROTEINS AND METHODS OF USE THEREOF |
| Release_Year | 2021 |
| Patent_ID | US20210177955A1 |